CTG Versus Collagen Matrix for Peri-Implant Soft Tissue Augmentation
NCT: NCT07371481 · RECRUITING
Brief Summary
This randomized controlled trial compares two techniques for peri-implant soft tissue augmentation in the mandibular molar region: an autogenous connective tissue graft (CTG) and a collagen matrix. Adult patients requiring implant treatment with insufficient peri-implant soft tissue thickness will be randomly assigned to receive either CTG or a collagen matrix at the time of implant surgery. The study aims to evaluate and compare changes in peri-implant soft tissue thickness, width of keratinized tissue, and soft tissue contour over a 9-month follow-up period, as well as the occurrence of postoperative complications. The results of this study will help determine whether a collagen matrix can provide clinical outcomes comparable to those of connective tissue grafting for peri-implant soft tissue augmentation.
Frequently Asked Questions
What is CTG Versus Collagen Matrix for Peri-Implant Soft Tissue Augmentation?
CTG Versus Collagen Matrix for Peri-Implant Soft Tissue Augmentation is a clinical trial registered under NCT07371481. Current status: RECRUITING.
What is the status of NCT07371481?
The current status of NCT07371481 (CTG Versus Collagen Matrix for Peri-Implant Soft Tissue Augmentation) is: RECRUITING.
When did CTG Versus Collagen Matrix for Peri-Implant Soft Tissue Augmentation start?
CTG Versus Collagen Matrix for Peri-Implant Soft Tissue Augmentation started on 2026-01-01.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.